Two Sigma Investments’s Urovant Sciences Ltd. UROV Stock Holding History

Two Sigma Investments’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-43,551	Closed	-$702K	–	4398
2020 Q4	$702K	Buy	+43,551	New	+$540K	﹤0.01%	2257
2019 Q2	–	Sell	-12,830	Closed	-$129K	–	3816
2019 Q1	$129K	Buy	12,830 +1,862	+17%	+$19.1K	﹤0.01%	2873
2018 Q4	$72K	Buy	+10,968	New	+$99.8K	﹤0.01%	2844

Two Sigma Investments's UROV Position: Q1 2021 in Review

Two Sigma Investments sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 43,551 shares — an estimated $702K sold.

Two Sigma Investments first reported a position in UROV in Q4 2018 and held it in 3 quarters. The position peaked at $702K in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

Two Sigma Investments reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Two Sigma Investments sold 43,551 Urovant Sciences Ltd. shares in Q1 2021, an estimated $702K.
Two Sigma Investments first reported a position in Urovant Sciences Ltd. in Q4 2018 and held it in 3 quarters.
Two Sigma Investments's Urovant Sciences Ltd. position peaked at $702K in Q4 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Two Sigma Investments's 13F filing for Q1 2021, filed 17 May 2021.